LAUREN RAMSEY: Open Payments
NPI 1114593209 · NORTH RICHLAND HILLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 27 payments from 15 companies in 2025. Trend: 2023 $631 · 2024 $929 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $120 |
| Amgen Inc. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Novo Nordisk Inc | 3 | $51 |
| Aurinia Pharma U.S., Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: TARPEYO, KRYSTEXXA, Ozempic, LUPKYNIS, Kerendia, COSENTYX, Vanrafia, JARDIANCE.
Industry payments across TX — which companies pay providers there.
